Advisor Group Holdings, Inc. Ab Cellera Biologics Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 343,075 shares of ABCL stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

343,075

Previous 268,001 28.01%

Holding current value

$1.27 Million

Previous $919,000 87.7%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.49 - $5.15 $262,008 - $386,631	75,074 Added 28.01%	343,075 $1.73 Million
Q2 2025 Sep 04, 2025	BUY	$1.93 - $3.8 $263,935 - $519,665	136,754 Added 104.2%	268,001 $919,000
Q2 2025 Aug 13, 2025	SELL	$1.93 - $3.8 $163,137 - $321,202	-84,527 Reduced 39.17%	131,247 $450,000
Q1 2025 May 12, 2025	BUY	$2.2 - $3.53 $245,099 - $393,273	111,409 Added 106.75%	215,774 $481,000
Q4 2024 Jun 06, 2025	SELL	$2.48 - $3.15 $207,724 - $263,844	-83,760 Reduced 38.82%	132,014 $386,000

Q4 2024 Feb 07, 2025	BUY	$2.48 - $3.15 $275 - $349	111 Added 0.11%	104,365 $305,000
Q3 2024 Nov 13, 2024	SELL	$2.39 - $3.49 $5,312 - $7,758	-2,223 Reduced 2.09%	104,254 $270,000
Q2 2024 Aug 13, 2024	BUY	$2.73 - $4.73 $4,449 - $7,709	1,630 Added 1.55%	106,477 $315,000
Q1 2024 May 10, 2024	BUY	$4.29 - $5.97 $11,535 - $16,053	2,689 Added 2.63%	104,847 $474,000
Q4 2023 Feb 12, 2024	SELL	$3.91 - $5.93 $373,925 - $567,103	-95,633 Reduced 48.35%	102,158 $583,000
Q3 2023 Nov 13, 2023	BUY	$4.6 - $7.95 $492,061 - $850,411	106,970 Added 117.78%	197,791 $909,000
Q2 2023 Aug 10, 2023	BUY	$5.66 - $7.59 $36,059 - $48,355	6,371 Added 7.54%	90,821 $586,000
Q1 2023 May 12, 2023	BUY	$7.31 - $11.18 $71,521 - $109,385	9,784 Added 13.1%	84,450 $636,000
Q4 2022 Feb 10, 2023	BUY	$9.48 - $14.52 $45,494 - $69,681	4,799 Added 6.87%	74,666 $756,000
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $196,291 - $291,876	21,336 Added 43.96%	69,867 $691,000
Q2 2022 Aug 10, 2022	BUY	$5.72 - $10.65 $44,799 - $83,410	7,832 Added 19.24%	48,531 $517,000
Q1 2022 May 04, 2022	BUY	$7.46 - $14.14 $206,007 - $390,476	27,615 Added 211.06%	40,699 $397,000
Q3 2021 Nov 05, 2021	BUY	$14.85 - $21.34 $103,756 - $149,102	6,987 Added 114.6%	13,084 $262,000
Q2 2021 Aug 02, 2021	BUY	$20.19 - $34.17 $30,809 - $52,143	1,526 Added 33.38%	6,097 $133,000
Q1 2021 May 13, 2021	BUY	$23.29 - $53.2 $72,688 - $166,037	3,121 Added 215.24%	4,571 $155,000
Q4 2020 Feb 10, 2021	BUY	$39.0 - $58.9 $56,550 - $85,405	1,450 New	1,450 $58,000

Others Institutions Holding ABCL

# of Institutions

169

Shares Held

109M

Call Options Held

1.26M

Put Options Held

788K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.05B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Ab Cellera Biologics Inc. Transaction History